We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current HXBM market cap is 2.7M. The company's latest EPS is USD -4.6994 and P/E is -2.55.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.16M | 1.84M | 2.37M | 1.76M | 998k |
| Operating Income | -516k | -1.22M | -1.3M | -1.19M | -1.11M |
| Net Income | -819k | -1.86M | -1.36M | -1.19M | -1.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.43M | 5.63M | 4.83M | 3.93M | 3.03M |
| Total Liabilities | 2.65M | 3.39M | 100k | 126k | 67k |
| Total Equity | 3.78M | 2.24M | 4.73M | 3.8M | 2.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -268k | -667k | -854k | -728k | -870k |
| Investing | -8k | -41k | -258k | 1.25M | 7k |
| Financing | 3M | 140k | 152k | N/A | N/A |
| Market Cap | 2.7M |
| Price to Earnings Ratio | -2.55 |
| Price to Sales Ratio | 2.7 |
| Price to Cash Ratio | 1.05 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 224.71k |
| Average Volume (1 week) | 108 |
| Average Volume (1 Month) | 108 |
| 52 Week Change | -48.43% |
| 52 Week High | 23.50 |
| 52 Week Low | 12.00 |
| Spread (Intraday) | 7.99 (44.41%) |
| Company Name | Helix Biomedix Inc (PK) |
| Address |
22118 20th ave se bothell 98021 |
| Website | https://www.helixbiomedix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
